Omnipod 5 Automated Glucose Control System

DEVICE2 trials

Sponsors

Insulet Corporation

Conditions

Diabetes MellitusType2 Diabetes

Unknown Phase

OP5-005 Using Omnipod 5 in Adults With Type 2

CompletedNCT05815342

Insulet CorporationType2 Diabetes

Start: 2023-04-11End: 2024-03-01Updated: 2025-09-29

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes

CompletedNCT06181721

Insulet CorporationDiabetes Mellitus

Start: 2023-09-05End: 2024-01-31Updated: 2024-04-02

Related Papers

Automated Insulin Delivery in Adults With Type 2 Diabetes

JAMA Network Open2025-02-1429 citations

1904-LB: Glycemic Improvement with Use of the Omnipod 5 Automated Insulin Delivery System in Adults with Type 2 Diabetes—Results of the SECURE-T2D Pivotal Trial

Diabetes2024-06-215 citations